Improving Wound Healing with Stem Cells and Dermal Substitutes
Author Information
Author(s): Wang Shiqi, Gao Dinghui, Li Mingyu, Wang Qian, Du Xuanyu, Yuan Siming, Bacci Stefano, Cervellati Franco
Primary Institution: Jinling Hospital, Nanjing University
Hypothesis
Transfection of DGTM factors into adipose-derived stem cells (ADSCs) will induce their differentiation into keratinocyte-like cells, and integrating these cells with Pelnac® dermal substitutes will enhance wound healing.
Conclusion
Combining DGTM factor-transfected ADSCs with dermal substitutes significantly improves the healing of full-thickness wounds.
Supporting Evidence
- Gene transfer using DGTM factors successfully induced keratinocyte differentiation in ADSCs.
- The application of these differentiated cells with Pelnac® dermal substitute resulted in the formation of skin tissue with a normal epidermal layer.
- This method alleviates the tediousness of multiple transfection steps in previous protocols.
- The inclusion of dermal substitutes promoted the formation of tissue resembling healthy skin rather than scar tissue.
- ADSCs exhibited normal growth and proliferation in Pelnac® during the nine-day co-culture period.
Takeaway
Scientists found a new way to help heal big skin wounds by using special cells from fat and a skin-like material together.
Methodology
The study involved transfecting ADSCs with DGTM factors and combining them with Pelnac® dermal substitutes, followed by testing in a mouse model.
Limitations
The simultaneous labeling of fluorescence was technically challenging due to the transfection of multiple genes.
Participant Demographics
C57BL/6J male mice, aged 6–8 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website